
Yale Technologies
Yale Ventures oversees Yale's technology transfer office, protecting and licensing the intellectual property developed at Yale, and helping to bring breakthroughs to market as products and services that can make a difference in the world.
Yale Technologies Available for Licensing
Yale Principal Investigator Pitches and Presentations
Search (Pitches)
Search (Pitches)
-
RESA therapeutics: programmable mRNAs for therapeutic aplications
Antonio Giraldez, PhD -
Machine-guided design of synthetic cell type-specific cis-regulatory elements for genetic therapies
Steven Reilly, PhD -
Neurolexa Therapeutics
Angelique Bordey, PhD -
Hybridex Biosciences: Enabling the Next Generation of Safe Gene Editing Therapeutics
Peter M. Glazer, M.D., Ph.D. -
Treating Epilepsy in an Orphan Genetically-Defined Disorder, Tuberous Scelerosis Complex (TSC)
Angelique Bordey, PhD -
-
A Probiotic Gene Cassette for Ulcerative Colitis Treatment
Jason Crawford, PhD, Associate Professor of Chemistry and Associate Professor of Microbial Pathogenesis -
Maegi Medicine: First-in-class Immune Gene Therapy for Human Health
Sidi Chen, Ph.D. -
Antibody-mediated gene editing and DNA/RNA delivery
Peter M. Glazer, M.D., Ph.D. -